Murat Tunaboylu is the Co-founder & CEO of Antiverse, an AI-first antibody drug discovery platform. Antiverse enables accelerated drug discovery for difficult targets by combining in-house lab expertise with state of the art machine learning. Antiverse has raised a total of £1.8M in funding. Their latest funding was raised in November 2020. Murat was a former software manager in a robotics company, automated DNA synthesis workflows at Thermo Fisher Scientific and has over 15 years experience. He studied Computer Engineering at Bahçeşehir Üniversitesi and has a degree in Electrical Engineering from Yildiz Technical University, Turkey. His current focus is to realise Antiverse's mission: engineering the future of drug discovery.